Welcome to the ValueWiki Avant Immunotherapeutics, Inc. (AVAN) article! Register for free or click the "edit" link to contribute!    

Avant Immunotherapeutics, Inc. (AVAN)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Avant Immunotherapeutics, Inc.? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max





Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

09/29/08 8:09 am Avant to become Celldex this week (at bizjournals.com)
09/29/08 7:09 am AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics (Business Wire)
09/18/08 3:09 pm AVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23 (Business Wire)
09/06/08 2:09 pm Taking Aim at Brain Cancer (at Forbes.com)
08/28/08 4:08 pm Taking Aim at Brain Cancer (at Forbes.com)
08/20/08 8:08 am AVANT IMMUNOTHERAPEUTICS INC Financials (EDGAR Online Financials)
08/12/08 10:08 am Look For These Stocks To Outperform Over The Next Five Days (at Forbes.com)
08/11/08 9:08 am Rocket Stock Watch List (at Forbes.com)
07/14/08 9:07 am Bobby Murcer Remembered (at CNBC)
06/20/08 10:06 am Unloved Stocks Ready to Shine (at Motley Fool)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Avant Immunotherapeutics, Inc. Snapshot
Avant Immunotherapeutics, Inc. Leadership
Avant Immunotherapeutics, Inc. Fundamentals
Avant Immunotherapeutics, Inc. Technical Analysis
Avant Immunotherapeutics, Inc. Message Boards

Notes

  1. This is a sample reference.
Personal tools